CONMED Corp. buy JPMorgan Chase & Co.
Start price
01.02.24
/
50%
€77.50
Target price
01.02.25
€106.18
Performance (%)
-12.43%
Price
24.07.24
€67.00
Summary
This prediction is currently active. The price of CONMED Corp. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.43%. Dividends of €0.37 are taken into consideration when calculating the performance. This prediction currently runs until 01.02.25. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
CONMED Corp. | -4.478% | -4.478% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at JPMorgan Chase & Co. from $135.00 to $115.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat